The global engineered cell therapy market, valued at USD 4.82 billion in 2023, is set for a remarkable growth trajectory, with a projected CAGR of 14.7% from 2023 to 2033. By 2033, the market is expected to reach a staggering USD 18.99 billion, driven by numerous factors, including increasing investments, rising disease incidence, and significant …